Skip to content
RxMonitor home

Active ingredient

Mirvetuximab Soravtansine

1 medication authorised for sale in Canada contains Mirvetuximab Soravtansine.

How it is classified

  • Antineoplastic and immunomodulating agents

The anatomical main group records the body system a medicine acts on. It is not a statement of what this ingredient treats, and nothing on this page is.

Products containing Mirvetuximab Soravtansine

Strengths and forms differ between these products — check them against your own. Containing the same active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

This is the only medication in Canada containing Mirvetuximab Soravtansine.

Only one authorised product in Canada contains this ingredient, so this page and that product’s page describe the same thing. That usually means no generic version has been authorised — not that alternatives were hidden.

Go to Elahere →

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12. Marketed human products only.

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.